Azenta announces collaboration with the lupus research alliance to support the advancement of lupus research and drug discovery

Azenta has been selected by the lupus research alliance as its sample management services provider and partner in supporting the development of the patient registry component of the lupus nexus burlington, mass. , may 24, 2023 /prnewswire/ -- azenta, inc. (nasdaq: azta) today announced it has been selected by the lupus research alliance and its clinical research affiliate lupus therapeutics to support the development of the patient registry component of the lupus nexus, which aims to advance and accelerate lupus research and drug discovery through information exchange capabilities.
AZTA Ratings Summary
AZTA Quant Ranking